For those who suffer with skin conditions like eczema, psoriasis and other sensitivities, choosing bedding that won’t irritate their skin can sometimes be challenging. Creating a solution for this consumer demographic drove the creative process behind bedding industry newcomer Lifeloom’s new Frictionless Sleep System.
The company teamed up with Precision Fabrics Group—producer of engineered fabrics ranging from medical textiles like gowns and drapes to acoustic fabrics for the automotive industry—to incorporate their DermaTherapy material into bed linens. The sheets made with DermaTherapy are woven with continuous filament fibers that don’t protrude beyond the planar surface of the fabric.
“The proprietary weave provides a much cleaner, hypoallergenic, lint-free surface, and that builds an enhanced microclimate,” said Bradley Seipp, chief operating officer for Lifeloom. “The less you irritate the skin, and the easier you can move in the sheets, the better you’ll sleep, even with sensitive skin.”
That weave gives the sheets a slicker feel, easing movement as compared to rougher fibers like cotton. The material also differs from other fabrics in its cleanability and resistance to bacteria and other irritants.
“We’ve all been sold on thread count, but most cotton-based products are difficult to clean,” Seipp said. “Whereas Lifeloom has a soil-release finish that allows any material that may aggregate into the bedding to clean better. Bacteria is significantly reduced because of the weave itself, and the fabrics are all hypoallergenic and have antimicrobial treatment.”
That cleanability factor has become even more important in the wake of the pandemic, and in an already-crowded bedding market, Seipp said Lifeloom has leaned on that to help differentiate itself.
“There’s so much noise out there, whether it’s silver-based products or copper-based products, and COVID has spawned awareness with bacteria and antimicrobials,” said Seipp. “And it was time to take a tech that’s been around a while—DermaTherapy was developed by PFG over a decade ago—and we knew it could help the industry do better.”
But simply saying the products improve sleep for those who suffer from skin conditions wasn’t enough, so Lifeloom subjected sheets from the Frictionless Sleep System to clinical testing by the Wake Forest University School of Medicine and the Society for Pediatric Dermatology. Those studies found the bedding helped reduce friction by 35 percent, improving symptoms of psoriasis and eczema, as well as reducing the symptoms of inflammatory acne by 49 percent.
Those results helped Lifeloom get approval from the U.S. Food and Drug Administration (FDA) for its DermaTherapy sheets to be classified as a Class I medical device for the treatment of certain skin conditions. Seipp said that was important for Lifeloom not only to reassure customers that its products actually do what they promise, but also as a means of standing out in a crowded marketplace.
“If you take the simple fact that we are an FDA-certified 510k medical device, and we have patents with DermaTherapy, it will be very hard for the competition to say anything like that,” he said.
Lifeloom has primarily sold the Frictionless Sleep System via e-commerce, but it also plans to debut the line to the wholesale retail channel later this month at the Las Vegas Market. And Seipp said the company also sees the potential to partner with other companies that want to incorporate its proprietary technology.
“We think this is a massive opportunity for established brands to differentiate themselves through licensing,” he said.
Seipp said the company also sees an opportunity to grow the business beyond just traditional bedding into other categories that could benefit from the skin-soothing benefits of DermaTherapy material.
“We’re starting with sleep, and that’s what we’re anchored in, but there are a lot of applications where we’re looking into expanding,” he said. “The infant and baby space, moving into apparel—if you’re sleeping on Lifeloom, but sleeping in traditional cotton PJs, you’re not getting the full effect.”